SCR-LIP-000259 · Claim · machine-readable JSON →
In a chart review of 46 women with lipedema (mean BMI 35.3 kg/m²), lipedema fat was associated with notably lower rates of metabolic dysfunction than expected for obesity (diabetes 2%, dyslipidemia 11.7%), is not reduced by lifestyle change, and is frequently misdiagnosed as obesity or lymphedema, with distinct distribution types and clinical staging.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-05-31 → 2026-06-10
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema: friend and foe — Torre et al. (2018) ✓ verified — consistent · case series · 2018 · reading confidence: moderate
“Perfil cardiometabólico PROTETOR apesar de IMC obeso médio 35,3±1,7 kg/m²: diabetes apenas 2% (vs. ~10% mulheres NHANES idade-pareada); dislipidemia 11,7% (vs. 33,5%); hipertensão 13% (vs. 32,4% mulheres 40-59 anos)”
The article describes lipedema as a distinct disorder frequently misdiagnosed as obesity or lymphedema, with characteristic fat distribution, staging, inheritance pattern, and a metabolic profile differing from obesity; supports the affirma
Context (PECO)
Answers these questions
- Is lipedema a distinct disease, separate from obesity and lymphedema? consistent
- Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-06-02 — merged · absorbed duplicate SCR-LIP-000150
- 2026-05-31 — created · auto-ingested for SQ-LIP-000001
- 2026-06-10 — statement revised · R-AI-14 integrity: removed unsourced comparator figures (10.7%/33.5%/'national norms'); kept the lipedema-group rates present in the source.